伤寒疫苗市场基于(主要地区、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00003752
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Typhoid Fever Vaccines Market Growth Report | 2021 to 2031

Buy Now

2021 年伤寒疫苗市场价值为 3.7676 亿美元,预计到 2031 年将达到 6.5187 亿美元。预计 2023-2031 年市场复合年增长率为 7.1%。联合伤寒疫苗的渗透可能仍是伤寒疫苗市场的主要趋势。

 

伤寒疫苗市场分析

 

伤寒发病率和死亡率上升加速对伤寒结合疫苗的需求

根据世界卫生组织 (WHO) 2023 年 3 月的报告,2019 年估计有 900 万人因伤寒患病,每年有 11 万人死于伤寒。此外,旅行者感染伤寒的风险很高,尤其是在亚洲和撒哈拉以南非洲。因此,随着发病率和死亡率的上升,对伤寒疫苗的需求空前高涨。例如,世卫组织建议各国采用伤寒结合疫苗 (TCV) 进行免疫,以控制流行地区的疾病。TCV 是第一种适用于 6 个月以上儿童的伤寒疫苗,是全球最受欢迎的伤寒疫苗选择。全球疫苗市场模型 (GVMM) 估计,中等收入国家 (MIC) 和低收入国家 (LIC) 的 TCV 总市场收入估计将达到 4400 万美元,仅占约 14% 的市场份额。 

来源:GVMM

此外,联合国儿童基金会 (UNICEF) 占有 95% 以上的 TCV 疫苗市场份额,尤其是在撒哈拉以南非洲、南亚和东南亚的低收入国家和中等收入国家。联合国儿童基金会在撒哈拉以南非洲、南亚和东南亚适当供应 TCV 疫苗,以减少人口中高负担的伤寒病例。因此,伤寒患病率和死亡率的上升、流行国家对伤寒疫苗的适当需求和供应是 2021-2031 年伤寒疫苗市场增长的影响因素。

 

伤寒疫苗市场概况

政府干预和智能疫苗配送解决方案继续对伤寒疫苗产生重大影响。政府对伤寒免疫接种的支持以及伤寒发病率和死亡率的上升是伤寒疫苗市场增长的最重要因素。联合伤寒疫苗是伤寒疫苗市场增长的关键趋势。开发三价伤寒/非伤寒沙门氏菌糖复合物疫苗的临床前研究将提供有利可图的市场机会。

 

Typhoid Fever Vaccines Market: Strategic Insights

Typhoid Fever Vaccines Market

  • CAGR (2023 - 2031)
    7.1%
  • Market Size 2021
    US$ 376.76 Million
  • Market Size 2031
    US$ 651.87 Million

Key Players

  • Indian Immunologicals
  • LBIP
  • Finlay
  • Incepta
  • Panacea
  • Bharat Biotech
  • Biological E
  • SK Biosciences
  • Zydus Cadila
  • BioMed

Regional Overview

  • 北美(美国、加拿大、墨西哥)
  • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
  • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
  • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
  • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)

Market Segmentation

疫苗类型(减毒活疫苗、荚膜多糖疫苗、结合疫苗、其他)
    给药途径(口服和注射)

       

      伤寒疫苗市场驱动因素和机遇

       

      政府支持伤寒免疫接种以利于市场

      政府对伤寒免疫接种的支持加速了全球对疫苗的需求。例如,澳大利亚联邦政府的报告显示,如果前往撒哈拉以南非洲、南亚和东南亚等疫区,建议2岁以下儿童和成人接种伤寒疫苗。此外,2岁以下儿童和成人可以接种1剂肠外伤寒疫苗,6岁以上儿童和成人可以接种3剂或4剂口服伤寒疫苗。

      此外,在加拿大,前往南亚(包括阿富汗、孟加拉国、不丹、印度、马尔代夫、尼泊尔、巴基斯坦和斯里兰卡)的 2 岁以上旅行者必须接种伤寒疫苗。因此,政府对伤寒免疫计划的支持将为伤寒疫苗市场在 2021-2031 年期间的成倍增长做出更多贡献。

       

      开发三价伤寒/非伤寒沙门氏菌糖复合物疫苗的临床前研究——一个机会

      2024年2月,SK Bioscience与国际疫苗研究所(IVI)宣布,SK Bioscience开发的伤寒结合疫苗已获得世界卫生组织(WHO)的联合国组织疫苗公共采购预认证(PQ),从而增加了全球TCV供应。“SKYTYPHOID”加强针的2期临床试验结果显示,6至23个月龄婴儿接种两剂TCV后产生了强烈的免疫反应。

      此外,一些制造商正在开发处于临床前阶段的 TCV。例如,制造商正在开发一种三价伤寒/非伤寒沙门氏菌糖复合物疫苗,特别是针对撒哈拉以南非洲的人口。此外,基于多抗原呈递系统 (MAPS) 的伤寒和副伤寒 A 疫苗的开发仍处于临床前阶段,是传统结合疫苗的有希望的替代品。因此,开发创新伤寒疫苗的临床研究将为最终推动伤寒疫苗市场的制造商提供有利可图的市场机会。

       

      伤寒疫苗

      市场报告细分分析

      有助于得出伤寒疫苗市场分析的关键部分是候选资格和服务。

      • 根据疫苗类型,伤寒疫苗市场分为减毒活疫苗、荚膜多糖疫苗、结合疫苗等。荚膜多糖疫苗在 2023 年可能会占据更大的市场份额。
      • 根据给药途径,伤寒疫苗市场分为口服和注射两种。注射剂市场在 2023 年可能会占据更大的市场份额。

       

      伤寒疫苗市场份额按地区分析

      伤寒疫苗市场报告的地理范围主要分为五个地区:北美洲、亚太地区、欧洲、中东和非洲、南美洲/南美洲和中美洲。

      北美主导着伤寒疫苗市场。在北美,美国在伤寒疫苗市场占有相当大的份额。北美拥有最大的伤寒疫苗市场份额和收入,因为医疗保健支出的增加和通过临床试验开发创新疫苗是推动市场增长的最重要因素。预计亚太地区未来几年将以最高的复合年增长率增长。  

       

      伤寒疫苗

      市场报告范围

       

      伤寒疫苗市场新闻和最新发展

      伤寒疫苗市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是伤寒疫苗市场的发展和策略列表:

      • 2023 年 11 月,韩国宣布一种新型伤寒疫苗结合物“Bio-TCV 伤寒结合疫苗 (TCV)”将在获得国家监管机构 Badan Pengawas Obat dan Makanan (BPOM) 的上市许可后在印度尼西亚获得许可。新疫苗“Bio-TCV”是一种 Vi 多糖结合疫苗。

       

      伤寒疫苗市场报告覆盖范围和交付成果

      “伤寒疫苗市场规模和预测(2021-2031)”报告对市场进行了详细分析,涵盖以下领域:

      • 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
      • 市场动态,如驱动因素、限制因素和关键机遇
      • 未来主要趋势
      • 详细的 PEST/波特五力分析和 SWOT 分析
      • 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
      • 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
      • 详细的公司简介

      伤寒疫苗市场报告范围

      报告属性细节
      2021 年市场规模3.7676亿美元
      2031 年市场规模6.5187亿美元
      全球复合年增长率(2023 - 2031)7.1%
      历史数据2021-2022
      预测期2023-2031
      涵盖的领域按疫苗类型
      • 减毒活疫苗
      • 荚膜多糖疫苗
      • 结合疫苗
      • 其他的
      按给药途径
      • 口服和注射
      覆盖地区和国家北美
      • 我们
      • 加拿大
      • 墨西哥
      欧洲
      • 英国
      • 德国
      • 法国
      • 俄罗斯
      • 意大利
      • 欧洲其他地区
      亚太
      • 中国
      • 印度
      • 日本
      • 澳大利亚
      • 亚太其他地区
      南美洲和中美洲
      • 巴西
      • 阿根廷
      • 南美洲和中美洲其他地区
      中东和非洲
      • 南非
      • 沙特阿拉伯
      • 阿联酋
      • 中东和非洲其他地区
      市场领导者和主要公司简介
      • 印度免疫学
      • 低收入国家计划
      • 芬利
      • 因塞普塔
      • 万能药
      • 印度生物科技公司
      • 生物E
      • SK 生物科学
      • 卡迪拉
      • 生物医学
      • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

      Typhoid Fever Vaccines Market Report Scope

      Report Attribute Details
      Market size in US$ 376.76 Million
      Market Size by US$ 651.87 Million
      Global CAGR 7.1%
      Historical Data 2021-2022
      Forecast period 2023-2031
      Segments Covered By 疫苗类型(减毒活疫苗、荚膜多糖疫苗、结合疫苗、其他)
      By 给药途径(口服和注射)
      Regions and Countries Covered 北美(美国、加拿大、墨西哥)
      • 北美(美国、加拿大、墨西哥)
      欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
      • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
      亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
      • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
      南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
      • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
      中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
      • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
      Market leaders and key company profiles
    • Indian Immunologicals
    • LBIP
    • Finlay
    • Incepta
    • Panacea
    • Bharat Biotech
    • Biological E
    • SK Biosciences
    • Zydus Cadila
    • BioMed
    • Report Coverage
      Report Coverage

      Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

      Segment Covered
      Segment Covered

      This text is related
      to segments covered.

      Regional Scope
      Regional Scope

      North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

      Country Scope
      Country Scope

      This text is related
      to country scope.

      The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

      1. Data Collection and Secondary Research:

      As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

      Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

      1. Primary Research:

      The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

      For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

      A typical research interview fulfils the following functions:

      • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
      • Validates and strengthens in-house secondary research findings
      • Develops the analysis team’s expertise and market understanding

      Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

      • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
      • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

      Below is the breakup of our primary respondents by company, designation, and region:

      Research Methodology

      Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

      1. Data Analysis:

      Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

      • Macro-Economic Factor Analysis:

      We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

      • Country Level Data:

      Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

      • Company Profile:

      The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

      • Developing Base Number:

      Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

      1. Data Triangulation and Final Review:

      The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

      We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

      We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

      Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

      Related Reports